Clinical Trials
Friday, February 17th, 2012
Journal of American Medical Association: Bridget M. Kuehn – Feb 15, 2012. KEYWORDS: biological markers, clinical trials as topic, national institute of neurological disorders and stroke, nervous system diseases, spinal muscular atrophies of childhood. With more than 600 neurological diseases—many of them rare—under its purview, the National Institute of Neurological Disorders and Stroke (NINDS) faces […]
Clinical Trials
Friday, February 17th, 2012
Last month, a series of studies published in BMJ reported various problems with clinical trial data. More specifically, there is a lot that goes unpublished. Although the Food and Drug Administration Amendments Act requires mandatory reporting of summary clinical trial results within one year of completion on ClinicalTrials.gov, one BMJ paper found that only 22 […]
Clinical Trials
Friday, February 10th, 2012
First ever data to demonstrate improvement in motor function following stroke with oral drug treatment initiated several weeks after event. HAWTHORNE, N.Y.–(BUSINESS WIRE)–Feb. 3, 2012– Acorda Therapeutics, Inc. (Nasdaq: ACOR) presented data showing that treatment with dalfampridine improved motor function in a preclinical model of stroke, with treatment initiated at least four weeks following the ischemic event. These […]
Clinical Trials
Friday, February 10th, 2012
MedWire News: The combination of clopidogrel and aspirin does not help, and may harm, patients with small subcortical stroke, show findings from the antiplatelet arm of the SPS3 trial. Patients given combination treatment had as many strokes as those given aspirin alone, and also had more bleeding events and were more likely to die during […]
Clinical Trials
Friday, February 10th, 2012
Postnoon News | February 8, 2012: Washington: An experimental stent-like device removed blood clots in stroke patients more effectively than standard mechanical treatment, a study reveals. Named SOLITAIRE, it has a self-expanding, stent-like design and, once inserted into a clot using a thin catheter tube, it compresses and traps the clot. The clot is then removed by withdrawing the […]
Clinical Trials, News
Wednesday, December 14th, 2011
The central pharmacologic approach to stroke prevention in atrial fibrillation has recently changed with the approval of dabigatran by the US Food and Drug Administration (FDA). Dabigatran is an oral anticoagulant that belongs to the class of direct thrombin inhibitors. Dabigatran has predictable pharmacokinetics, without significant drug and food interactions, rapid onset, and requires twice-daily administration without the need […]
Clinical Trials
Thursday, November 17th, 2011
Medicalxpress: Community rehabilitation interventions for stroke patients have not had a great track record of delivering measurable improvements. But new research from New Zealand focused on Maori and Pacific populations shows how a cheap and simple intervention that puts the patient and families in charge can make a difference to their quality of life. The study […]
Clinical Trials
Thursday, November 17th, 2011
Big Data Analytics Reduced from Days to Minutes to Help Prevent Future Death and Disability from Many Conditions REDWOOD CITY, Calif.–(BUSINESS WIRE)–Actian Corporation (formerly Ingres Corp) today announced that CTSU (the MRC/Cancer Research UK/BHF Clinical Trial Service Unit & Epidemiological Studies Unit of Oxford University) has selected Vectorwise to extract and analyze data pertaining to the causes, prevention and treatment […]
